FTC Makes 'Significant Progress' In OptumRx, Caremark Talks
By Bryan Koenig · March 3, 2026, 1:50 PM EST
Federal Trade Commission staffers got more time Tuesday for settlement talks with OptumRx and Caremark that could end the agency's case accusing the pharmacy benefit managers of inflating insulin prices, with...
To view the full article, register now.